PHILADELPHIA, PA — IntegriChain has launched an AI-driven State Price Transparency Reporting (SPTR) platform designed to help pharmaceutical manufacturers meet growing state-level reporting mandates. The new system blends automation, regulatory expertise, and analytics to simplify complex compliance processes for drug pricing disclosures.
Developed with input from several top 20 pharmaceutical companies, the SPTR platform employs machine learning to automatically detect required reports, collect and process pricing data from multiple systems, and adjust dynamically to new regulations. Its unified data structure and single sign-on integration provide users with centralized access to reporting tools and compliance dashboards across all ICyte modules.
With more than 110 pharmaceutical manufacturers currently using its transparency reporting services, IntegriChain has positioned itself as a leading vendor in the space. The company’s credibility was further elevated by the appointment of Lynetta Moore, one of its regulatory experts, to the Oregon Rulemaking Committee — a move that signals the firm’s influence in shaping policy and compliance standards.
IntegriChain CEO Josh Halpern said the platform offers a comprehensive, market-leading solution grounded in regulatory experience, relationships with state agencies, and a strong compliance record. Chief AI and Technology Officer Shai Fiss said the roadmap goes beyond automating filings to incorporate learning systems, with planned use of natural language processing and anomaly detection across state submissions to reduce errors and accelerate compliance cycles.
As transparency mandates continue to expand nationwide, IntegriChain’s AI-powered SPTR system aims to help drugmakers stay ahead of shifting requirements while reducing administrative burdens and compliance risks.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.